Drug Concept Normalization

Drug Concept Normalization is a knowledge representation process that maps diverse textual mentions of pharmaceutical substances to standardized, unique identifiers within a curated drug ontology, thereby enabling consistent semantic interpretation across heterogeneous biomedical data sources.

4

Publications

113

Citations

18

Authors

8

Institutions

Publications per year

2017–2026

3

Authors

18

  1. ZM
    Zulfat Miftahutdinov

    Kazan Federal University, Russia

    1 publications · 31 citations

    1

    h-index

  2. HR
    Harold R. Solbrig

    Mayo Clinic in Florida, United States

    1 publications · 15 citations

    1

    h-index

  3. ET
    Elena Tutubalina

    Kazan Federal University, Russia

    1 publications · 31 citations

    1

    h-index

  4. MS
    Mark Sharp

    National Institute of Arthritis and Musculoskeletal and Skin Diseases, United States

    1 publications · 30 citations

    1

    h-index

  5. KC
    Kelsy C. Cotto

    Washington University in St. Louis, United States

    1 publications · 37 citations

    1

    h-index

1–5 of 18

Venues

  1. PubMed

    Repository · 1 publications · 15 citations

    1

    h-index

  2. Journal of Biomedical Semantics

    JBMS · 1 publications · 30 citations

    1

    h-index

  3. Bioinformatics

    1 publications · 31 citations

    1

    h-index

  4. bioRxiv (Cold Spring Harbor Laboratory)

    Repository · 1 publications · 37 citations

    1

    h-index

1–4